Erectile dysfunction and coronary artery disease prediction: Evidence-based guidance and consensus

International Journal of Clinical Practice

Volumn 64, Issue 7, 2010, Pages 848-857

  Jackson, G ^a   Boon, N ^b   Eardley, I ^c   Kirby, M ^d   Dean, J ^e   Hackett, G ^f   Montorsi, P ^g   Montorsi, F ^h   Vlachopoulos, C ⁱ   Kloner, R ^j   Sharlip, I ^k   Miner, M ^l  

^a LONDON BRIDGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^e Nuffield Clinic   (United Kingdom)

^f UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF MILAN   (Italy)

^h VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

ⁱ HIPPOKRATION HOSPITAL   (Greece)

^j UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l BROWN UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL; TESTOSTERONE; VARDENAFIL;

ANGIOCARDIOGRAPHY; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; ELECTROCARDIOGRAPHY; ERECTILE DYSFUNCTION; EVIDENCE BASED PRACTICE; EXERCISE; FUNDING; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MALE; MALE GENITAL SYSTEM FUNCTION; MEDICAL ASSESSMENT; MORTALITY; OUTCOME ASSESSMENT; PENIS ERECTION; PHYSICAL ACTIVITY; PREDICTION; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SEXUAL BEHAVIOR; SMOKING CESSATION; STRATEGIC PLANNING; SYMPTOMATOLOGY; WEIGHT REDUCTION;

ALGORITHMS; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHIES; HEALTH PROMOTION; HUMANS; IMPOTENCE, VASCULOGENIC; MALE; RISK FACTORS; TESTOSTERONE;

EID: 77952726042     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02410.x     Document Type: Review

References (105)

1. Hatzimouratidis K, Amar E, Eardley I et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. Published on-line 20 February 2010.
2. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999 11: 319 326.
3. Chiurlia E, D'Amico R, Ratti C, Granata AR, Romagnoli R, Modena MG. Subclinical coronary artery atherosclerosis in patients with erectile dysfunction. J Am Coll Cardiol 2005 46: 1503 1506.
4. Vlachopoulos C, Rokkas K, Ioakeimidis N, Stefanadis C. Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links. Eur Urol 2007 52: 1590 1600.
5. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994 151: 54 61.
6. Burchardt M, Burchardt T, Baer L et al. Hypertension is associated with severe erectile dysfunction. J Urol 2000 164: 1188 1191.
7. Giuliano FA, Leriche A, Jaudinot EO, de Gendre AS. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology 2004 64: 1196 1201.
8. Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med 2006 166: 207 212.
9. Montorsi F, Briganti A, Salonia A et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease Eur Urol 2003 44: 360 364 discussion 364-365.
10. Solomon H, Man J, Wierzbicki AS, O'Brien T, Jackson G. Erectile dysfunction: cardiovascular risk and the role of the cardiologist. Int J Clin Pract 2003 57: 96 9.
11. El-Sakka AI, Morsy AM. Screening for ischemic heart disease in patients with erectile dysfunction: role of penile Doppler ultrasonography. Urology 2004 64: 346 350.
12. Jackson G, Padley S. Erectile dysfunction and silent coronary artery disease: abnormal computed tomography coronary angiogram in the presence of normal exercise ECGs. Int J Clin Pract 2008 62: 973 976.
13. Ma RC, So WY, Yang X et al. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J Am Coll Cardiol 2008 51: 2045 2050.
14. Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ. Impaired brachial artery endothelium-dependent and-independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004 43: 179 184.
15. Borgquist R, Gudmundsson P, Winter R, Nilsson P, Willenheimer R. Erectile dysfunction in healthy subjects predicts reduced coronary flow velocity reserve. Int J Cardiol 2006 112: 166 170.
16. Foresta C, Palego P, Schipilliti M, Selice R, Ferlin A, Caretta N. Asymmetric development of peripheral atherosclerosis in patients with erectile dysfunction: an ultrasonographic study. Atherosclerosis 2008 197: 889 895.
17. Yaman O, Gulpinar O, Hasan T, Ozdol C, Ertas FS, Ozgenci E. Erectile dysfunction may predict coronary artery disease relationship between coronary artery calcium scoring and erectile dysfunction severity. Int Urol Nephrol 2008 40: 117 123.
18. Billups KL, Kaiser DR, Kelly AS et al. Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction. Int J Impot Res 2003 15: 231 236.
19. Roumeguere T, Wespes E, Carpentier Y, Hoffmann P, Schulman CC. Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary heart disease risk. Eur Urol 2003 44: 355 359.
20. El-Sakka AI, Morsy AM, Fagih BI, Nassar AH. Coronary artery risk factors in patients with erectile dysfunction. J Urol 2004 172: 251 254.
21. Vlachopoulos C, Aznaouridis K, Ioakeimidis N et al. Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur Heart J 2006 27: 2640 2648.
22. Min JK, Williams KA, Okwuosa TM, Bell GW, Panutich MS, Ward RP. Prediction of coronary heart disease by erectile dysfunction in men referred for nuclear stress testing. Arch Intern Med 2006 166: 201 206.
23. Montorsi P, Ravagnani PM, Galli S et al. Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J 2006 27: 2632 2639.
24. Ward RP, Weiner J, Taillon LA, Ghani SN, Min JK, Williams KA. Comparison of findings on stress myocardial perfusion imaging in men with versus without erectile dysfunction and without prior heart disease. Am J Cardiol 2008 101: 502 505.
25. Salem S, Abdi S, Mehrsai A et al. Erectile dysfunction severity as a risk predictor for coronary artery disease. J Sex Med 2009 6: 3425 3432.
26. Kawanishi Y, Lee KS, Kimura K et al. Screening of ischemic heart disease with cavernous artery blood flow in erectile dysfunctional patients. Int J Impot Res 2001 13: 100 103.
27. Shamloul R, Ghanem HM, Salem A et al. Correlation between penile duplex findings and stress electrocardiography in men with erectile dysfunction. Int J Impot Res 2004 16: 235 237.
28. Montorsi P, Ravagnani PM, Galli S et al. Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient. Eur Urol 2006 50: 721 731. (Pubitemid 44332685) (Pubitemid 44332685)
29. Baumhakel M, Bohm M. Erectile dysfunction correlates with left ventricular function and precedes cardiovascular events in cardiovascular high-risk patients. Int J Clin Pract 2007 61: 361 366.
30. Hodges LD, Kirby M, Solanki J, O'Donnell J, Brodie DA. The temporal relationship between erectile dysfunction and cardiovascular disease. Int J Clin Pract 2007 61: 2019 2025.
31. Chew KK, Finn J, Stuckey B et al. Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings from a linked-data study. J Sex Med 2010 7: 192 202.
32. Inman BA, Sauver JL, Jacobson DJ et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 2009 84: 108 113.
33. Ponholzer A, Temml C, Obermayr R, Wehrberger C, Madersbacher S. Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur Urol 2005 48: 512 518.
34. Thompson IM, Tangen CM, Goodman PJ, Probstfield JL, Moinpour CM, Coltman CA. Erectile dysfunction and subsequent cardiovascular disease. JAMA 2005 294: 2996 3002.
35. Schounten BW, Bohnen AM, Bosch JL et al. Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen Study. Int J Impot Res 2008 20: 92 9.
36. Araujo AB, Travison TG, Ganz P et al. Erectile dysfunction and mortality. J Sex Med 2009 6: 2445 2454.
37. Montorsi P, Ravagnani PM, Galli S et al. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol 2005 96: 19M 23M.
38. Vlachopoulos C, Rokkas K, Ioakeimidis N et al. Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study Eur Urol 2005 48: 996 1002 discussion 1002-1003.
39. Solomon H, Man J, Martin E, Jackson G. Role of exercise treadmill testing in the management of erectile dysfunction: a joint cardiovascular/erectile dysfunction clinic. Heart 2003 89: 671 672.
40. Armstrong WF, Pellikka PA, Ryan T, Crouse L, Zoghbi WA. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 1998 11: 97 104.
41. Nieman K, Galema TW, Neefjes LA et al. Comparison of the value of coronary calcium detection to computed tomographic angiography and exercise testing in patients with chest pain. Am J Cardiol 2009 104: 1499 1504.
42. Wong ND, Gransar H, Shaw L et al. Thoracic aortic calcium versus coronary artery calcium for the prediction of coronary heart disease and cardiovascular disease events. JACC Cardiovasc Imaging 2009 2: 319 326.
43. Esposito K, Giugliano F, Di Palo C et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 2004 291: 2978 2984.
44. Cheng JY, Ng EM. Body mass index, physical activity and erectile: dysfunction an U-shaped relationship from population-based study. Int J Obes (Lond) 2007 31: 1571 1578.
45. Revnic CR, Nica AS, Revnic F. The impact of physical training on endocrine modulation, muscle physiology and sexual functions in elderly men. Arch Gerontol Geriatr 2007 44 (Suppl. 1 339 342.
46. Esposito K, Ciotola M, Giugliano F et al. Mediterranean diet improves erectile function in subjects with the metabolic syndrome. Int J Impot Res 2006 18: 405 410.
47. Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000 56: 302 306.
48. Kostis JB, Jackson G, Rosen R et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 2005 96: 313 321. (Pubitemid 40978596) (Pubitemid 40978596)
49. Grimm RH, Jr., Grandits GA, Prineas RJ et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension 1997 29: 8 14.
50. Blumentals WA, Brown RR, Gomez-Caminero A. Antihypertensive treatment and erectile dysfunction in a cohort of type II diabetes patients. Int J Impot Res 2003 15: 314 317.
51. Schwarz ER, Rastogi S, Rodriguez JJ et al. A multidisciplinary approach to assess erectile dysfunction in high-risk cardiovascular patients. Int J Impot Res 2005 17 (Suppl. 1 S37 43.
52. Böhm M, Baumhakel M, Probstfield JL et al. Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND). Am Heart J 2007 154: 94 101.
53. Shiri R, Koskimaki J, Hakkinen J, Auvinen A, Tammela TL, Hakama M. Cardiovascular drug use and the incidence of erectile dysfunction. Int J Impot Res 2007 19: 208 212.
54. Rizvi K, Hampson JP, Harvey JN. Do lipid-lowering drugs cause erectile dysfunction? A systematic review. Fam Pract 2002 19: 95 8.
55. Solomon H, Samarasinghe YP, Feher MD et al. Erectile dysfunction and statin treatment in high cardiovascular risk patients. Int J Clin Pract 2006 60: 141 145.
56. Do C, Huyghe E, Lapeyre-Mestre M, Montastruc JL, Bagheri H. Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database. Drug Saf 2009 32: 591 597.
57. Doumas M, Tsakiris A, Douma S et al. Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients. Asian J Androl 2006 8: 177 182.
58. Jackson G, Betteridge J, Dean J et al. A systematic approach to erectile dysfunction in the cardiovascular patient: a Consensus Statement-update 2002. Int J Clin Pract 2002 56: 663 671.
59. Fogari R, Zoppi A, Poletti L, Marasi G, Mugellini A, Corradi L. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens 2001 14: 27 31.
60. Dusing R. Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men. Blood Press Suppl 2003 2: 29 34.
61. Baumhakel M, Schlimmer N, Bohm M. Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome. Int J Impot Res 2008 20: 493 500.
62. Saltzman EA, Guay AT, Jacobson J. Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation. J Urol 2004 172: 255 258.
63. Gokkaya SC, Ozden C, Levent Ozdal O, Hakan Koyuncu H, Guzel O, Memis A. Effect of correcting serum cholesterol levels on erectile function in patients with vasculogenic erectile dysfunction. Scand J Urol Nephrol 2008 42: 437 440.
64. Gazzaruso C, Solerte SB, Pujia A et al. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. J Am Coll Cardiol 2008 51: 2040 2044.
65. Fox KM, Thadani U, Ma PT et al. Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina. Eur Heart J 2003 24: 2206 2212.
66. Vardi Y, Bulus M, Reisner S et al. Effects of sildenafil citrate (Viagra) on hemodynamic parameters during exercise testing and occurrence of ventricular arrhythmias in patients with erectile dysfunction and cardiovascular disease. Eur Urol 2003 43: 544 551.
67. Webster LJ, Michelakis ED, Davis T, Archer SL. Use of sildenafil for safe improvement of erectile function and quality of life in men with New York Heart Association classes II and III congestive heart failure: a prospective, placebo-controlled, double-blind crossover trial. Arch Intern Med 2004 164: 514 520.
68. Katz SD, Parker JD, Glasser DB et al. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure. Am J Cardiol 2005 95: 36 42.
69. DeBusk RF, Pepine CJ, Glasser DB, Shpilsky A, DeRiesthal H, Sweeney M. Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease. Am J Cardiol 2004 93: 147 153. (Pubitemid 38058721) (Pubitemid 38058721)
70. Pickering TG, Shepherd AM, Puddey I et al. Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial. Am J Hypertens 2004 17: 1135 1142.
71. van Ahlen H, Wahle K, Kupper W, Yassin A, Reblin T, Neureither M. Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives. J Sex Med 2005 2: 856 864.
72. Kloner RA, Sadovsky R, Johnson EG, Mo D, Ahuja S. Efficacy of tadalafil in the treatment of erectile dysfunction in hypertensive men on concomitant thiazide diuretic therapy. Int J Impot Res 2005 17: 450 454.
73. Valiquette L, Montorsi F, Auerbach S. First-dose success with vardenafil in men with erectile dysfunction and associated comorbidities: RELY-I. Int J Clin Pract 2006 60: 1378 1385.
74. Miner M, Gilderman L, Bailen J et al. Vardenafil in men with stable statin therapy and dyslipidemia. J Sex Med 2008 5: 1455 1467.
75. Mittleman MA, Maclure M, Glasser DB. Evaluation of acute risk for myocardial infarction in men treated with sildenafil citrate. Am J Cardiol 2005 96: 443 446.
76. Jackson G, Kloner RA, Costigan TM, Warner MR, Emmick JT. Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events. J Sex Med 2004 1: 161 167.
77. Giuliano F, Jackson G, Montorsi F, Martin-Morales A, Raillard P. Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database. Int J Clin Pract 2010 64: 240 255.
78. Boolell M, Allen MJ, Ballard SA et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996 8: 47 52.
79. Pryor J. Vardenafil: update on clinical experience. Int J Impot Res 2002 14 (Suppl. 1 S65 9.
80. Jackson G, Martin E, McGing E, Cooper A. Successful withdrawal of oral long-acting nitrates to facilitate phosphodiesterase type 5 inhibitor use in stable coronary disease patients with erectile dysfunction. J Sex Med 2005 2: 513 516. (Pubitemid 40975836) (Pubitemid 40975836)
81. Jackson G, Rosen RC, Kloner RA, Kostis JB. The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med 2006 3: 28 36.
82. Yassin AA, Saad F. Testosterone and erectile dysfunction. J Androl 2008 29: 593 604.
83. Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR. Low serum testosterone and mortality in male veterans. Arch Intern Med 2006 166: 1660 1665.
84. Khaw KT, Dowsett M, Folkerd E et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: european prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 2007 116: 2694 2701.
85. Maggio M, Lauretani F, Ceda GP et al. Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study. Arch Intern Med 2007 167: 2249 2254.
86. Traish AM, Saad F, Feeley RJ, Guay A. The dark side of testosterone deficiency: III. Cardiovascular disease. J Androl 2009 30: 477 494.
87. Basaria S, Dobs AS. Testosterone making an entry into the cardiometabolic world. Circulation 2007 116: 2658 2661.
88. Jackson G. Cardiovascular effects of testosterone. Curr Sex Health Rep 2008 5: 187 189.
89. Qaseem A, Snow V, Denberg TD et al. Hormonal testing and pharmacologic treatment of erectile dysfunction: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2009 151: 639 649.
90. Caminiti G, Volterrani M, Iellamo F et al. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 2009 54: 919 927.
91. English KM, Steeds RP, Jones TH, Diver MJ, Channer KS. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation 2000 102: 1906 1911.
92. Gazzaruso C, Giordanetti S, De Amici E et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 2004 110: 22 6.
93. National Collaborating Centre for Chronic Conditions. Type 2 Diabetes. National Clinical Guidelines for Management in Primary and Secondary Care (Update).
94. Vardi M, Nini A Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus Cochrane Database Syst Rev 2007: CD002187.
95. Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA 1999 281: 421 426.
96. Stuckey BG, Jadzinsky MN, Murphy LJ et al. Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial. Diabetes Care 2003 26: 279 284.
97. Safarinejad MR. Oral sildenafil in the treatment of erectile dysfunction in diabetic men: a randomized double-blind and placebo-controlled study. J Diabetes Complications 2004 18: 205 210.
98. Ishii N, Nagao K, Fujikawa K, Tachibana T, Iwamoto Y, Kamidono S. Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction. Int J Urol 2006 13: 1066 1072.
99. Boulton AJ, Selam JL, Sweeney M, Ziegler D. Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus. Diabetologia 2001 44: 1296 1301.
100. Saenz de Tejada I, Anglin G, Knight JR, Emmick JT. Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes Care 2002 25: 2159 2164.
101. Goldstein I, Young JM, Fischer J, Bangerter K, Segerson T, Taylor T. Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study. Diabetes Care 2003 26: 777 783.
102. Ziegler D, Merfort F, van Ahlen H, Yassin A, Reblin T, Neureither M. Efficacy and safety of flexible-dose vardenafil in men with type 1 diabetes and erectile dysfunction. J Sex Med 2006 3: 883 891.
103. Guay AT, Perez JB, Jacobson J, Newton RA. Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors. J Androl 2001 22: 793 797.
104. Böhm M, Baumhäkel M, Koon T et al. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril or both. Circulation 2010 121: 1439 1446.
105. Jackson G. Prevention of cardiovascular disease by the early identification of erectile dysfunction. Int J Impot Res 2008 20 (Suppl. 2 S9 14.